Skip to main content

PAH Risk Score Calculators

Frequent risk assessments inform treatment decisions

According to today’s treatment recommendations, patients with pulmonary arterial hypertension (PAH) should receive an objective, multiparameter risk assessment at diagnosis and follow-up risk assessments as often as every 3 months thereafter.1,2

These risk calculation tools can help you quickly calculate your patient’s risk score with point-and-click ease. You can choose from among 5 calculators.

Use these online tools to calculate your patient’s risk status and help inform initial and follow-up treatment approaches

At diagnosis

REVEAL 2.0

2022 ESC/ERS Treatment Guidelines

During follow-up

REVEAL Lite 2

COMPERA 2.0: 4‑Risk Strata

French Noninvasive Criteria

How to use calculator tools:

Download Instructions
PAH Initiative Risk Score Calculator App

PAH Initiative Risk Score Calculator App

PAH Initiative has created a Risk Score Calculator App to assist in calculating risk scores using guidelines and other methodologies. Explore this exciting new tool

Download Risk Calculator App

Discuss risk with your patients

Help your patients become more invested in achieving low risk. Use the handouts below to facilitate conversations with your patients.

Patient Risk Infographic

Use this infographic to help your patients understand the importance of improving their risk status

Risk Calculator Sheets

Download this PDF for a copy of the of REVEAL 2.0, REVEAL Lite 2, 2022 ESC/ERS Treatment Guidelines, and COMPERA 2.0 4-Risk Strata calculation methods

PAH Initiative Monitoring Guide

PAH Monitoring Guide

Review key elements of monitoring risk status and right heart parameters in your PAH patients

If your patient is not at low risk, adjusting their treatment plan may help improve prognosis1

Examine Treatment Guidelines
COMPERA=Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension; ERS=European Respiratory Society; ESC=European Society of Cardiology; REVEAL=Registry to EValuate Early And Long-term pulmonary arterial hypertension disease management.
References: 1. Humbert M, et al. Eur Heart J. 2022;43(38):3618-3731. 2. Dardi F, et al. Eur Respir J. 2024;64(4):2401323.
Various calculators on the PAH Risk Score Calculator app